七月 2026
- Home
- Exeltis Usa, Inc
七月 2026的Exeltis Usa, Inc市场份额分析
at exeltis, we’re focused and fearless, going above and beyond to deliver better health options to our patients. we insist on—and deliver—extraordinary in everything we do.
Exeltis Usa, Inc(包含公司地区分支机构)
查看更多网站流量和参与度信息- exeltisusa.com
Exeltis Usa, Inc热门域名的总访问量
了解Exeltis Usa, Inc市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Exeltis Usa, Inc热门域名的平均访问时长
分析Exeltis Usa, Inc参与度指标。
过去 3 个月的平均访问时长
子公司明细
Exeltis Usa, Inc热门域名的平均页面浏览量
了解Exeltis Usa, Inc如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Exeltis Usa, Inc 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Exeltis USA, Inc. sold assets to Alembic Therapeutics LLC on Jun 9th '26.Alembic Therapeutics, LLC announces acquisition of NUVESSA(R)(metronidazole vaginal gel 1.3%) from Exeltis USA, Inc.
六月 9, 2026阅读更多
新闻Agile Therapeutics, Inc. partners with Exeltis USA, Inc..Agile Therapeutics has combined with Insud Pharma's US Subsidiary, Exeltis USA, Inc., expanding an already significant women's health/contraceptive portfolio
八月 26, 2024阅读更多
新闻Exeltis USA, Inc. launches Let's Love Every Body.FLORHAM PARK, N.J., May 08, 2024-(BUSINESS WIRE)-Exeltis USA, Inc., a division of the global pharmaceutical group Insud Pharma, today announced "Let's Love Every Body," a national campaign designed to empower women to live life to the fullest while loving and accepting their bodies.
五月 8, 2024阅读更多
查看 Exeltis Usa, Inc 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。
